Wednesday, 4 October 2023

NANOSTRING, A*STAR'S GIS, NLG TO SET UP SPATIAL BIOLOGY LABORATORY IN SINGAPORE

KUALA LUMPUR, Oct 4 (Bernama) -- NanoString Technologies Inc, a leader in spatial biology, has entered into a collaboration with Agency for Science,Technology and Research (A*STAR)’s Genome Institute of Singapore (GIS), and Next Level Genomics (NLG), to establish a joint laboratory in Singapore.

According to NanoString in a statement, the joint laboratory focuses on the application of spatial biology to identify biomarkers that can predict disease progression and treatment response.

The new lab, called the Spatial Atlas of Clinical Evolution of Disease (SpACE-Dx) lab, will harness spatial multiomic (gene and protein expression) technologies to drive research in complex diseases, with a primary focus on cancer.

The SpACE-Dx lab will be situated within A*STAR’s GIS facility, accessible to the local research community, aiming to foster collaboration and accelerate advancements in spatial genomics research.

NanoString Director of Sales for Asia Pacific and Japan, Dr Jay Manikandan said: “We are delighted to partner with A*STAR’s GIS and NLG, taking the next step forward to support our mission to advance science and improve health.

“As a leader in spatial biology with the most powerful laboratory tools available on the market today, including the CosMx SMI, GeoMx DSP, and AtoMx platforms, we see the joint lab as an important resource for our customers in Singapore and the greater region.”

NanoString’s platforms allow researchers to measure the multi-modal expression of genes and proteins in the natural context of tissue structure, including diseased cells such as cancer cells and the cells within their microenvironment (stromal and immune cells).

The technologies enable scientists to determine how cells change and interact during the development and progression of disease.

A*STAR brings to the table its advanced scientific infrastructure and expertise in genomics research, sequencing technologies, data analytics, and spatial omics in the areas of translational cancer biology, infectious disease, and neurobiology.

Meanwhile, NLG, the provider of next-generation sequencing services focused on long-read technologies, will provide the laboratory expertise in spatial genomics utilising NanoString instruments to aid researchers in applying cutting-edge spatial technology to their ongoing research.

-- BERNAMA

No comments:

Post a Comment